These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7746026)

  • 1. Bioequivalence of two commercially available levothyroxine-Na preparations in athyreotic patients.
    Gottwald R; Lorkowski G; Petersen G; Schnitzler M; Lücker PW
    Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):645-50. PubMed ID: 7746026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study.
    Di Girolamo G; Keller GA; de Los Santos AR; Schere D; Gonzalez CD
    Clin Ther; 2008 Nov; 30(11):2015-23. PubMed ID: 19108789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioequivalence study of levothyroxine tablets compared to reference tablets and an oral solution.
    Koytchev R; Lauschner R
    Arzneimittelforschung; 2004; 54(10):680-4. PubMed ID: 15553108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism.
    Dong BJ; Hauck WW; Gambertoglio JG; Gee L; White JR; Bubp JL; Greenspan FS
    JAMA; 1997 Apr; 277(15):1205-13. PubMed ID: 9103344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new method for the determination of the bioavailability of thyroid hormone preparations.
    Trantow T; Herzog R; Gegenheimer L; Lücker PW
    Methods Find Exp Clin Pharmacol; 1994 Mar; 16(2):133-40. PubMed ID: 8007742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New questions regarding bioequivalence of levothyroxine preparations: a clinician's response.
    Green WL
    AAPS J; 2005 Mar; 7(1):E54-8. PubMed ID: 16146330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioequivalence of levothyroxine tablets administered to a target population in steady state.
    Cerutti R; Rivolta G; Cavalieri L; Di Giulio C; Grossi E; Vago T; Baldi G; Righini V; Marzo A
    Pharmacol Res; 1999 Mar; 39(3):193-201. PubMed ID: 10094844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A bioequivalence study of levothyroxine tablets versus an oral levothyroxine solution in healthy volunteers.
    Yannovits N; Zintzaras E; Pouli A; Koukoulis G; Lyberi S; Savari E; Potamianos S; Triposkiadis F; Stefanidis I; Zartaloudis E; Benakis A
    Eur J Drug Metab Pharmacokinet; 2006; 31(2):73-8. PubMed ID: 16898074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current methodology to assess bioequivalence of levothyroxine sodium products is inadequate.
    Blakesley VA
    AAPS J; 2005 Mar; 7(1):E42-6. PubMed ID: 16146348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid hormone levels affected by time of blood sampling in thyroxine-treated patients.
    Ain KB; Pucino F; Shiver TM; Banks SM
    Thyroid; 1993; 3(2):81-5. PubMed ID: 8369656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TSH-based protocol, tablet instability, and absorption effects on L-T4 bioequivalence.
    Eisenberg M; Distefano JJ
    Thyroid; 2009 Feb; 19(2):103-10. PubMed ID: 19191742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative bioequivalence study of a new levothyroxine solution versus a reference L-thyroxine solution in normal healthy volunteers.
    Chassard D; Kerihuel JC; Caplain H; Tran Quang N; Thebault JJ
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():324-6. PubMed ID: 1820903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An investigation into the influence of experimental conditions on in vitro drug release from immediate-release tablets of levothyroxine sodium and its relation to oral bioavailability.
    Kocic I; Homsek I; Dacevic M; Parojcic J; Miljkovic B
    AAPS PharmSciTech; 2011 Sep; 12(3):938-48. PubMed ID: 21748540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study between the effects of replacement therapy with liquid and tablet formulations of levothyroxine on mood states, self-perceived psychological well-being and thyroid hormone profile in recently thyroidectomized patients.
    Lombardi CP; Bocale R; Barini A; Barini A; D'Amore A; Boscherini M; Bellantone R
    Endocrine; 2017 Jan; 55(1):51-59. PubMed ID: 27388589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When Bioequivalence in Healthy Volunteers May not Translate to Bioequivalence in Patients: Differential Effects of Increased Gastric pH on the Pharmacokinetics of Levothyroxine Capsules and Tablets.
    Seng Yue C; Benvenga S; Scarsi C; Loprete L; Ducharme MP
    J Pharm Pharm Sci; 2015; 18(5):844-55. PubMed ID: 26670370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of a physiologic replacement dose of levothyroxine in elderly patients with hypothyroidism.
    Davis FB; LaMantia RS; Spaulding SW; Wehmann RE; Davis PJ
    Arch Intern Med; 1984 Sep; 144(9):1752-4. PubMed ID: 6433829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical Markers Reflecting Thyroid Function in Athyreotic Patients on Levothyroxine Monotherapy.
    Ito M; Miyauchi A; Hisakado M; Yoshioka W; Ide A; Kudo T; Nishihara E; Kihara M; Ito Y; Kobayashi K; Miya A; Fukata S; Nishikawa M; Nakamura H; Amino N
    Thyroid; 2017 Apr; 27(4):484-490. PubMed ID: 28056660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differences in the effectiveness of levothyroxine preparations].
    Wenzel KW; Mehrländer U
    Dtsch Med Wochenschr; 1987 Jan; 113(2):53-8. PubMed ID: 3322763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative bioavailability of two oral L-thyroxine formulations after multiple dose administration in patients with hypothyroidism and its relation with therapeutic endpoints and dissolution profiles.
    Vaisman M; Spina LD; Eksterman LF; dos Santos MJ; Lima JS; Volpato NM; da Silva RL; de Brito AP; Noël F
    Arzneimittelforschung; 2001; 51(3):246-52. PubMed ID: 11304941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generic and brand-name L-thyroxine are not bioequivalent for children with severe congenital hypothyroidism.
    Carswell JM; Gordon JH; Popovsky E; Hale A; Brown RS
    J Clin Endocrinol Metab; 2013 Feb; 98(2):610-7. PubMed ID: 23264396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.